首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer biology & medicine

缩写:

ISSN:2095-3941

e-ISSN:2095-3941

IF/分区:12.4/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1069条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Li Li,Kexin Sun,Xiang Li et al. Li Li et al.
Objective: Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related mortality worldwide. This study was aimed at estimating regional and national variations in lifetime CRC ri...
Qirong Li,Yi Guo,Jiahuan Yuan et al. Qirong Li et al.
Objective: Gastric cancer (GC) is a prevalent malignant tumor that warrants the development of drugs and therapeutic targets. Cuproptosis has emerged as a promising mechanism by which to inhibit tumors because copper home...
Yuting Luo,Yiran Cai,Zizheng Jiang et al. Yuting Luo et al.
Objective: Bone metastases are refractory to current therapies, primarily owing to the immunosuppressive metastasis tumor microenvironment (TME), which is dominated by myeloid cells. However, the function and regulatory m...
Qingyuan Liu,Boyang Wang,Shao Li Qingyuan Liu
Objective: Transcriptomic perturbation profiles from tumor cell lines serve as the core molecular basis for cancer drug discovery and mechanism of action (MOA) analysis. Traditional Chinese medicine (TCM) holds great anti...
Weijia Kong,Hengna Lin,Jie Li et al. Weijia Kong et al.
Objective: Breast cancer is the most frequently diagnosed cancer among women worldwide and is a leading cause of cancer-related deaths. Comparative assessments of breast cancer lifetime risks across populations are limite...
Ke-En Tan,Kok Siong Yeo,Yat-Yuen Lim et al. Ke-En Tan et al.
Neuroblastoma (NB) is a pediatric cancer that develops from immature nerve cells in the peripheral sympathetic nervous system. NB is remarkably heterogeneous, ranging from spontaneous regression to aggressive progression, and is characteriz...
Kexin Feng,Jun Wang,Shuai Wang et al. Kexin Feng et al.
Lung cancer is a fatal and the most common malignancy globally. Despite the significant therapeutic benefits of immune checkpoint inhibitors (ICIs), 60%-80% of patients respond poorly to immunotherapy. The identification of reliable predict...
Ruoxi Tian,Ziyue Sha,Shasha Zhang et al. Ruoxi Tian et al.
Objective: We aimed to evaluate chemotherapy-free apatinib-based immunotherapy regimens for patients with human epidermal growth factor receptor 2 (HER2)-positive gastric cancer (GC) who were chemotherapy-intolerant or de...